BIOL - BIOLASE, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue46,92651,81048,475
Cost of Revenue31,80031,50232,525
Gross Profit15,12620,30815,950
Operating Expenses
Research Development6,2297,7997,283
Selling General and Administrative26,93527,47129,313
Non Recurring---731
Others---
Total Operating Expenses---
Operating Income or Loss-18,038-14,962-19,915
Income from Continuing Operations
Total Other Income/Expenses Net605-258-185
Earnings Before Interest and Taxes-17,433-15,220-20,100
Interest Expense---
Income Before Tax-17,433-15,220-20,100
Income Tax Expense-582151178
Minority Interest---
Net Income From Continuing Ops-16,851-15,371-20,278
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-16,851-15,371-20,278
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-20,829-17,555-20,278